INVO Fertility, Inc. (IVF) stock forecast & analysis
1 analysis. Latest: .
Market Scanner’s AI analysis of INVO Fertility, Inc. (IVF), updated August 2026: INVO Fertility's recent reports focused on revenue growth and clinic profitability amidst a declining stock price.
Summary
INVO Fertility's recent reports focused on revenue growth and clinic profitability amidst a declining stock price.
Recent analyses for INVO Fertility (IVF) covered a 17% year-over-year quarterly revenue growth and improvements in clinic-level profitability. The company's stock price has experienced a significant downtrend, trading below key moving averages and showing bearish momentum according to technical indicators. Financials indicate negative profit and operating margins despite revenue increases.
IVF news & sentiment
News reports highlighted INVO Fertility's strong quarterly revenue growth and improved clinic profitability, noting its mention among top premarket gainers. Social media discussions were not covered in the provided notes.
IVF technical picture
The stock price has been in a strong long-term downtrend, trading significantly below its 50-day and 200-day simple moving averages. Short-term momentum is also negative, with the price below the 10-day exponential moving average. Momentum indicators like the RSI and MACD suggest bearish momentum, while the MFI indicates some selling pressure but not oversold conditions.
Fundamentals
The company reported year-over-year quarterly revenue growth and clinic-level profitability improvements. However, analyses also covered negative profit and operating margins, alongside a negative return on equity.
Factors discussed — upside
- Year-over-year quarterly revenue growth of 16.7%
- Improvement in clinic-level profitability
- Mentioned among top premarket gainers
Factors discussed — risks
- Stock price trading significantly below 50-day and 200-day SMAs
- Negative profit margin of -70.18% TTM
- Negative operating margin of -59.28% TTM
- Negative Return on Equity TTM of -55.28%
- Bearish momentum indicated by RSI and MACD
- Revenue growth
- Profitability
- Technical indicators
- Market performance
Summary updated .
Analyses
Recent IVF.US analyses are locked — sign in to read them or generate a fresh one.
Frequently asked questions
- What is the bull case for INVO Fertility, Inc.?
- Recent analyses highlighted year-over-year quarterly revenue growth of 16.7% and improvements in clinic-level profitability. The company was also noted among top premarket gainers.
- What are the risks for INVO Fertility, Inc.?
- The company's stock price is trading significantly below its 50-day and 200-day simple moving averages, indicating a strong long-term downtrend. Financial performance shows a negative profit margin of -70.18% and a negative operating margin of -59.28% on a trailing twelve months basis, alongside a negative Return on Equity TTM. Technical indicators such as the RSI and MACD suggest bearish momentum.
- Is INVO Fertility, Inc. bullish or bearish?
- Recent AI analyses of INVO Fertility, Inc. examined factors on both sides. Discussed upside: Recent analyses highlighted year-over-year quarterly revenue growth of 16.7% and improvements in clinic-level profitability. The company was also noted among top premarket gainers. Discussed risks: The company's stock price is trading significantly below its 50-day and 200-day simple moving averages, indicating a strong long-term downtrend. Financial performance shows a negative profit margin of -70.18% and a negative operating margin of -59.28% on a trailing twelve months basis, alongside a negative Return on Equity TTM. Technical indicators such as the RSI and MACD suggest bearish momentum. These are descriptive observations, not a recommendation.
- What is the latest sentiment on INVO Fertility, Inc.?
- News reports highlighted INVO Fertility's strong quarterly revenue growth and improved clinic profitability, noting its mention among top premarket gainers. Social media discussions were not covered in the provided notes.
- Bundles used
- gemini-low-v2
Sign in to read every IVF.US report in the library
Each analysis includes the full reasoning, dissent, and decision rationale from the structured AI pipeline.